Profile change history

What changed for Dalbavancin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Dalbavancin identity.

46Total events
46Record additions
0Version changes
12Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 46 connected records →

Showing the latest 46 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 17, 2026.

Record added

Federal Register notice 2014-02942

The Federal Register published notice 2014-02942, attributed to FDA and its parent HHS department, on 2014-02-12. Its official title is “Anti-Infective Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Dalbavancin.

PeptideScanner change date
November 17, 2026
Cited source date
February 12, 2014
Evidence lane
Regulatory
Record added

Federal Register notice 2018-02768

The Federal Register published notice 2018-02768, attributed to FDA and its parent HHS department, on 2018-02-12. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; DALVANCE,” and PeptideScanner's exact reviewed identity mapping connects the document to Dalbavancin.

PeptideScanner change date
November 17, 2026
Cited source date
February 12, 2018
Evidence lane
Regulatory
Record added

Federal Register notice 2019-09007

The Federal Register published notice 2019-09007, attributed to FDA and its parent HHS department, on 2019-05-03. Its official title is “21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Dalbavancin.

PeptideScanner change date
November 17, 2026
Cited source date
May 3, 2019
Evidence lane
Regulatory
Record added

Federal Register notice 2026-15149

The Federal Register published notice 2026-15149, attributed to FDA and its parent HHS department, on 2026-07-28. Its official title is “Pediatric Advisory Committee (PAC); Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Dalbavancin.

PeptideScanner change date
November 17, 2026
Cited source date
July 28, 2026
Evidence lane
Regulatory
Record added

ClinicalTrials.gov record NCT00678106

PeptideScanner retained ClinicalTrials.gov record NCT00678106 at 2026-11-16T17:37:42.807Z. Its registry update date was 2009-10-12, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
October 12, 2009
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01339091

PeptideScanner retained ClinicalTrials.gov record NCT01339091 at 2026-11-16T17:37:42.807Z. Its registry update date was 2014-01-31, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
January 31, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01946568

PeptideScanner retained ClinicalTrials.gov record NCT01946568 at 2026-11-16T17:37:42.807Z. Its registry update date was 2015-06-23, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
June 23, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02127970

PeptideScanner retained ClinicalTrials.gov record NCT02127970 at 2026-11-16T17:37:42.807Z. Its registry update date was 2018-09-28, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
September 28, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02685033

PeptideScanner retained ClinicalTrials.gov record NCT02685033 at 2026-11-16T17:37:42.807Z. Its registry update date was 2019-01-04, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
January 4, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02814916

PeptideScanner retained ClinicalTrials.gov record NCT02814916 at 2026-11-16T17:37:42.807Z. Its registry update date was 2024-09-19, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
September 19, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02961764

PeptideScanner retained ClinicalTrials.gov record NCT02961764 at 2026-11-16T17:37:42.807Z. Its registry update date was 2020-04-10, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
April 10, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03233438

PeptideScanner retained ClinicalTrials.gov record NCT03233438 at 2026-11-16T17:37:42.807Z. Its registry update date was 2020-01-18, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
January 18, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04959799

PeptideScanner retained ClinicalTrials.gov record NCT04959799 at 2026-11-16T17:37:42.807Z. Its registry update date was 2022-09-21, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
September 21, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05046860

PeptideScanner retained ClinicalTrials.gov record NCT05046860 at 2026-11-16T17:37:42.807Z. Its registry update date was 2026-06-22, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
June 22, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06810583

PeptideScanner retained ClinicalTrials.gov record NCT06810583 at 2026-11-16T17:37:42.807Z. Its registry update date was 2026-09-15, and PeptideScanner's reviewed identity mapping was dalbavancin.

PeptideScanner change date
November 16, 2026
Cited source date
September 15, 2026
Evidence lane
Clinical trials
Record added

The role of dalbavancin in the multi-disciplinary management of wound infections in orthopaedic surgery.

PubMed lists PMID 29168673 in Journal of chemotherapy (Florence, Italy) as Journal Article, Review, with publication-date metadata of 2017-11-23 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 26, 2018
Evidence lane
Literature metadata
Record added

Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections.

PubMed lists PMID 29258361 in Expert opinion on drug metabolism & toxicology as Comparative Study, Journal Article, Review, with publication-date metadata of 2017-12-25 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
February 22, 2018
Evidence lane
Literature metadata
Record added

The role of dalbavancin in skin and soft tissue infections.

PubMed lists PMID 29298166 in Current opinion in infectious diseases as Journal Article, Review, with publication-date metadata of 2018-04 (month precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 18, 2019
Evidence lane
Literature metadata
Record added

Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis.

PubMed lists PMID 31087630 in Clinical pharmacology in drug development as Clinical Trial, Phase II, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-05-14 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 31, 2021
Evidence lane
Literature metadata
Record added

The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs).

PubMed lists PMID 32223465 in Expert review of anti-infective therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2020-03-29 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 11, 2021
Evidence lane
Literature metadata
Record added

Dalbavancin for the management of osteomyelitis: a major step forward?

PubMed lists PMID 32457989 in The Journal of antimicrobial chemotherapy as Journal Article, Review, with publication-date metadata of 2020-10-01 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 22, 2021
Evidence lane
Literature metadata
Record added

Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review.

PubMed lists PMID 32603683 in International journal of antimicrobial agents as Journal Article, Systematic Review, with publication-date metadata of 2020-06-27 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review.

PubMed lists PMID 32629114 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2020-07-03 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Current trends in the real-life use of dalbavancin: report of a study panel.

PubMed lists PMID 32721599 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2020-07-25 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 27, 2021
Evidence lane
Literature metadata
Record added

Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review.

PubMed lists PMID 33962065 in Journal of global antimicrobial resistance as Journal Article, Review, with publication-date metadata of 2021-05-04 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 1, 2021
Evidence lane
Literature metadata
Record added

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review.

PubMed lists PMID 34072670 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2021-05-31 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 10, 2021
Evidence lane
Literature metadata
Record added

Dalbavancin.

PubMed lists PMID 34598419 in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia as Journal Article, Review, with publication-date metadata of 2021-09-30 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 30, 2021
Evidence lane
Literature metadata
Record added

Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review.

PubMed lists PMID 34923922 in Journal of chemotherapy (Florence, Italy) as Journal Article, Review, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 15, 2022
Evidence lane
Literature metadata
Record added

Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin.

PubMed lists PMID 34931283 in Clinical pharmacokinetics as Journal Article, Review, with publication-date metadata of 2021-12-21 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 10, 2026
Evidence lane
Literature metadata
Record added

Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios.

PubMed lists PMID 35353020 in Expert review of anti-infective therapy as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-04-08 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 15, 2022
Evidence lane
Literature metadata
Record added

Global trends of dalbavancin: A bibliometric analysis.

PubMed lists PMID 35735062 in Journal of clinical pharmacy and therapeutics as Journal Article, Review, with publication-date metadata of 2022-06-23 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 24, 2023
Evidence lane
Literature metadata
Record added

The current and future off-label uses of dalbavancin: a narrative review.

PubMed lists PMID 36808371 in European review for medical and pharmacological sciences as Review, Journal Article, with publication-date metadata of 2023-02 (month precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Dalbavancin in Bone and Joint Infections: A Systematic Review.

PubMed lists PMID 37513919 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2023-07-15 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 1, 2023
Evidence lane
Literature metadata
Record added

A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections.

PubMed lists PMID 37887193 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2023-09-28 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 29, 2023
Evidence lane
Literature metadata
Record added

Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis.

PubMed lists PMID 38449918 in Open forum infectious diseases as Clinical Trial, Journal Article, with publication-date metadata of 2024-02-07 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 8, 2024
Evidence lane
Literature metadata
Record added

Dalbavancin as long-term treatment in Corynebacterium striatum Infections: a literature review.

PubMed lists PMID 38533780 in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia as Letter, Review, with publication-date metadata of 2024-03-27 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 18, 2024
Evidence lane
Literature metadata
Record added

Dalbavancin for the treatment of bone and joint infections: A meta-analysis.

PubMed lists PMID 39029624 in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2024-07-17 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 14, 2025
Evidence lane
Literature metadata
Record added

Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients.

PubMed lists PMID 40001365 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2025-01-23 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
February 28, 2025
Evidence lane
Literature metadata
Record added

[Translated article] Therapeutic drug monitoring of dalbavancin: A systematic review of strategies and clinical applications in the treatment of complex infections.

PubMed lists PMID 40993014 in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria as Systematic Review, Journal Article, with publication-date metadata of 2025-09-23 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 18, 2026
Evidence lane
Literature metadata
Record added

Proactive Therapeutic Drug Monitoring of Dalbavancin in the Long-Term Treatment of Chronic Infections: A Narrative Review.

PubMed lists PMID 41892415 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-03-01 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata